AR039184A1 - Supositorios de meloxicam - Google Patents

Supositorios de meloxicam

Info

Publication number
AR039184A1
AR039184A1 ARP030101097A ARP030101097A AR039184A1 AR 039184 A1 AR039184 A1 AR 039184A1 AR P030101097 A ARP030101097 A AR P030101097A AR P030101097 A ARP030101097 A AR P030101097A AR 039184 A1 AR039184 A1 AR 039184A1
Authority
AR
Argentina
Prior art keywords
meloxicam
suppositories
pharmaceutically acceptable
excipients
composition
Prior art date
Application number
ARP030101097A
Other languages
English (en)
Inventor
Mayumi Matsui
Toshimitsu Ohki
Koichi Wada
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR039184A1 publication Critical patent/AR039184A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un supositorio que contiene una composición, que consiste esencialmente en meloxicam o una de sus sales farmacéuticamente aceptables y al menos un excipiente farmacéuticamente aceptable, caracterizado porque al menos uno de los excipientes es un polialquilenglicol.
ARP030101097A 2002-03-30 2003-03-28 Supositorios de meloxicam AR039184A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007455A EP1348436A1 (en) 2002-03-30 2002-03-30 Meloxicam suppositories

Publications (1)

Publication Number Publication Date
AR039184A1 true AR039184A1 (es) 2005-02-09

Family

ID=27798842

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101097A AR039184A1 (es) 2002-03-30 2003-03-28 Supositorios de meloxicam

Country Status (9)

Country Link
EP (2) EP1348436A1 (es)
JP (1) JP2005521714A (es)
AR (1) AR039184A1 (es)
AU (1) AU2003219113A1 (es)
CA (1) CA2479914A1 (es)
PE (1) PE20040308A1 (es)
TW (1) TW200306862A (es)
UY (1) UY27741A1 (es)
WO (1) WO2003082297A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPH0816051B2 (ja) * 1988-12-07 1996-02-21 エスエス製薬株式会社 徐放性坐剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
JPH07100191A (ja) * 1993-10-06 1995-04-18 Daikyo Yakuhin Kogyo Kk 徐放性坐剤
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
AU750125B2 (en) * 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen

Also Published As

Publication number Publication date
EP1348436A1 (en) 2003-10-01
UY27741A1 (es) 2003-10-31
TW200306862A (en) 2003-12-01
CA2479914A1 (en) 2003-10-09
JP2005521714A (ja) 2005-07-21
AU2003219113A1 (en) 2003-10-13
WO2003082297A1 (en) 2003-10-09
PE20040308A1 (es) 2004-07-06
EP1492538A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
UY26380A1 (es) Inhibidores de fab i
AR031130A1 (es) N-acilsulfonamidas promotoras de la apoptosis
UY27972A1 (es) Derivados de hidantoína
NO20054369L (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
ECSP024352A (es) Nueva composicion farmaceutica
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
DK1320540T3 (da) Peptidomimetiske proteaseinhibitorer
LU92024I2 (fr) Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR)
TR200200129T2 (tr) Hepatit C inhibitörü tri-peptidler
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
CO5251409A1 (es) Combinacion de un inhibidor de la recaptacion de seretonina e irandalona
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DE60010098D1 (de) 28-epirapaloge
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
LU92182I2 (fr) Dapagliflozine et ses sels pharmaceutiquement acceptables
ECSP056065A (es) Composiciones farmacéuticas para inhibidores de la proteasa del virus de la hepatitis C
NO20033220D0 (no) Inhibitorer for cruzipain og andre cysteinproteaser
AR039184A1 (es) Supositorios de meloxicam
CO5280222A1 (es) Composicion farmaceutica que comprende pemetrexed
AR033467A1 (es) Comprimido de meloxicam de rapida disgregacion
AR021241A1 (es) Inhibidores de proteasas
EA200200798A1 (ru) Кальцилитические соединения
UY26680A1 (es) Inhibidor del intercambiador de sodio-hidrógeno de tipo 1.